|
|
More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.
Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.
The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.
After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.
Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.